Physician profile
Rayan Hourani
NPI 1265638811
$20,399.58
in general payments reported to CMS, 2019-2025
53 companies · $2,251 in 2025
The $2,251 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,240 · 2020: $2,432 · 2021: $3,477 · 2022: $2,929 · 2023: $2,245 · 2024: $2,826 · 2025: $2,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,320 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,319.90 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,580.99 | 2019-2025 | Xience Skypoint, Navitor, Mitraclip |
| Medtronic, INC. | $1,560.40 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Micra |
| Novartis Pharmaceuticals Corporation | $1,164.11 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,120.81 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,083.25 | 2019-2025 | Brilinta, Andexxa, Farxiga |
| Edwards Lifesciences Corporation | $1,063.23 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Shockwave Medical, INC | $949.38 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $937.81 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $745.09 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $719.69 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $698.46 | 2019-2024 | |
| Philips North America LLC | $559.36 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $530.00 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $475.40 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.21 | 2019-2025 | Jardiance |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $407.76 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $390.86 | 2019-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $379.18 | 2020-2025 | Nexletol |
| Penumbra, INC. | $309.23 | 2020-2025 | Indigo System |
| Biotronik INC. | $273.59 | 2019-2022 | |
| Inari Medical, INC. | $251.38 | 2021-2022 | |
| Abiomed | $240.46 | 2019-2025 | Impella |
| Amarin Pharma, INC. | $237.69 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $209.52 | 2023-2025 | Verquvo |
| Heartflow, INC. | $178.21 | 2024-2025 | |
| Cardiovascular Systems INC. | $172.69 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $137.27 | 2019-2023 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $134.09 | 2021-2022 | |
| Teleflex LLC | $129.60 | 2022 | |
| Cvrx, INC. | $100.06 | 2021-2025 | Barostim Neo System |
| Zoll Circulation INC | $98.28 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $97.00 | 2019-2025 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $90.58 | 2021-2025 | |
| Lexicon Pharmaceuticals, INC. | $90.25 | 2023-2024 | Inpefa |
| Gilead Sciences, INC. | $84.57 | 2019 | |
| Scpharmaceuticals INC. | $74.64 | 2024-2025 | |
| Cleerly, INC. | $71.60 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Angiodynamics, INC. | $66.76 | 2022-2023 | Alphavac |
| Chiesi USA, INC. | $66.43 | 2019-2023 | Kengreal |
| Alnylam Pharmaceuticals INC. | $57.49 | 2023-2025 | Amvuttra |
| Daiichi Sankyo INC. | $55.15 | 2023 | Injectafer |
| Kestra Medical Technology Services, INC. | $53.51 | 2023-2024 | Assure Wcd |
| Cardinal Health 200 LLC | $50.46 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $44.29 | 2022 | |
| Inspire Medical Systems, INC. | $34.14 | 2025 | Inspire |
| Irhythm Technologies, INC. | $26.59 | 2024 | Zio Monitor, Zio Xt Patch |
| Mannkind Corporation | $24.28 | 2025 | |
| Lundbeck LLC | $22.39 | 2019 | |
| Trevena, INC. | $21.09 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.54 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $17.65 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Getinge USA Sales, LLC | $15.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.03 | 2023 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rayan Hourani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.